SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,572 Cr | ₹1,531 Cr | ₹1,484 Cr | ₹1,487 Cr | ₹1,443 Cr |
What is the latest Total Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹1,572 Cr |
Mar2024 | ₹1,531 Cr |
Mar2023 | ₹1,484 Cr |
Mar2022 | ₹1,487 Cr |
Mar2021 | ₹1,443 Cr |
How is Total Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹1,572 Cr | 2.68 | |
Mar2024 | ₹1,531 Cr | 3.19 | |
Mar2023 | ₹1,484 Cr | -0.19 | |
Mar2022 | ₹1,487 Cr | 3.02 | |
Mar2021 | ₹1,443 Cr | - |
Compare Total Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹4,694.4 Cr | 1.2% | -1% | 31.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 1.2% |
-1% |
31.3% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses